Scor


08/05/25 -"We have updated our model to reflect Scor’s 1Q25 results and revised our assumptions for FY25 and beyond. The results were well ahead of expectations across both Life & Health and P&C, despite ..."

Pages
63
Language
English
Published on
08/05/25
You may also be interested by these reports :
03/03/26
AXA delivered a strong set of FY25 results, with resilient top-line growth and margins, despite a more competitive environment in P&C Commercial ...

03/03/26
We have incorporated AXA’s recently published FY25 results into our model and revised our assumptions for FY26 and the following years. In 2025, AXA ...

02/03/26
We have adopted a more optimistic scenario for FY26 and the subsequent years following Swiss Re’s 4Q25 results. In particular, we have revised our ...

27/02/26
While Swiss Re’s 4Q25 net income declined 32% y/y, this was largely expected, reflecting the impacts of the reserve review in L&H, as well as added ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO